SCHEMBL7333103

SCHEMBL7333103

O=C(CI)N1CC2CC(=NOCc3ccccc3)CC2C1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HSD11B1 P28845 1/20 0.41
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36
MMP7 P09237 1/20 0.36
MMP13 P45452 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
GRM5 P41594 2/20 0.34
HTR2C P28335 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433532 0.81 JAK2 (0.48) NPC1RAB9AHSD11B1
SCHEMBL20237058 0.71 NPC1 (0.48) NPC1RAB9AHSD11B1MMP1MMP3
SCHEMBL18484113 0.67 HSD11B1 (0.45) NPC1RAB9AHSD11B1MEN1KMT2A
SCHEMBL2045062 0.66 NPC1 (0.59) NPC1RAB9AHSD11B1CYP3A4CYP2C9
SCHEMBL2045918 0.66 NPC1 (0.59) NPC1RAB9AHSD11B1
SCHEMBL16601272 0.65 SMN1; SMN2 (0.56) NPC1RAB9AMEN1KMT2ANPSR1
SCHEMBL20548406 0.65 SMN1; SMN2 (0.56) NPC1RAB9AMEN1KMT2ANPSR1
SCHEMBL16199651 0.65 SMN1; SMN2 (0.56) NPC1RAB9AMEN1KMT2ANPSR1
SCHEMBL16608211 0.65 SMN1; SMN2 (0.56) NPC1RAB9AMEN1KMT2ANPSR1
SCHEMBL1249749 0.65 NPC1 (0.42) NPC1RAB9AMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627190-A TREATMENT OF ANXIETY, PSYCHOSES, DEPRESSION, ORGASTROINTESTINAL DISORDERS, 5-HYDROXYTRYPTAMINE ANTAGONISTS G. D. SEARLE & CO. (US) 1997-05-06 US disclosed
US-5612366-A USEFUL IN TREATMENT OF CENTRAL NERVOUS SYSTEM AND GASTROINTESTINAL MOTILITY DISORDERS G. D. SEARLE & CO. (US) 1997-03-18 US disclosed
US-5516782-A FOR TREATMENT OF ANXIETY, PSYCHOSES, DEPRESSION OR GASTROINTESTINAL MOTILITY DISTURBANCES G. D. SEARLE & CO. (US) 1996-05-14 US disclosed
US-5430040-A Anxiolytic agents, antidepressants, antiserotonine agents; treatment of psychosis, gastrointestinal disorders G. D. SEARLE & CO. (US) 1995-07-04 US disclosed
US-5318977-A New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents G. D. SEARLE & CO. (US) 1994-06-07 US disclosed
US-5280029-A Containing imidazolo(1,5-a)pyridine G. D. SEARLE & CO. (US) 1994-01-18 US disclosed
US-5234921-A Antagonists of the serotonin 5-HT3 receptor; gastrointestinal disorders; antidepressants; drug abuse G. D. SEARLE & CO. (US) 1993-08-10 US disclosed
US-5227377-A Serotonin 5-HT3 receptor antagonists G. D. SEARLE & CO. (US) 1993-07-13 US disclosed
US-5219850-A Anyiolytic agents, gastrointestinal disorders, antiserotonin agents G. D. SEARLE & CO. (US) 1993-06-15 US disclosed
US-5196547-A Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof G. D. SEARLE & CO. (US) 1993-03-23 US disclosed
EP-0504680-A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents G.D. Searle & Co. (US) 1992-09-23 EP disclosed
WO-1992015590-A1 NEW MESO-AZACYCLIC AROMATIC ACID AMIDES AND ESTERS AS NOVEL SEROTONERGIC AGENTS G.D. SEARLE & CO. (US) 1992-09-17 WO disclosed
US-5137893-A Anxilytic agents; antidepressants; antiemetics G. D. SEARLE & CO. (US) 1992-08-11 US disclosed